InvestorsHub Logo
Followers 33
Posts 2837
Boards Moderated 2
Alias Born 10/24/2015

Re: NY1972 post# 205

Thursday, 01/05/2023 8:16:27 PM

Thursday, January 05, 2023 8:16:27 PM

Post# of 391
Hopefully, there will be additional trials as not only do a number of studies show an association between higher frequencies of TAMs and poor prognosis across different types, but also they can mediate therapeutic resistance.

The clinical data from OR2805 (+/- an anti-PD-1, chemo, or an anti-EGFR) will be interesting as well https://jitc.bmj.com/content/9/Suppl_2/A294
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News